Seguimiento ambulatorio de pacientes con lupus en una unidad de enfermedades autoinmunes sistémicas

  1. Aguilar Huergo, Sergio
  2. Vargas Hitos, José Antonio
  3. Navarrete Navarrete, N.
  4. Zamora Pasadas, Mónica
  5. Sabio Sánchez, José Mario
  6. Jiménez Alonso, Juan Francisco
Journal:
Actualidad médica

ISSN: 0365-7965

Year of publication: 2013

Tome: 98

Issue: 789

Pages: 70-73

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Actualidad médica

Sustainable development goals

Abstract

Objectives: To describe the symptoms referred by the patients with systemic lupus erythematosus (SLE) during their ambulatory follow-up by an Autoinmune Disease Unit (ADU), the relationship between them and SLE itself or with other clinic entities and the need to refer lupus patients to other specialists. Methods: We performed a descriptive analysis during 5 months that included 112 patients with SLE with ambulatory follow-up by an ADU. We assessed the symptomatology suffered by the patients since the last visit, related or not to SLE, and the prevalence of patients referred to other specialists. Results: Eighty (71.4%) patients had symptoms no explainable by SLE, mainly due to arthralgias secondary to osteoarthrosis and anxiety-depressive syndrome. Thirty-two (23.5%) patients had symptoms related to SLE, the most frequent of which were articular flare in 10 (8.3%) patients, lupus nephritis in 8 (7.1%) and skin flare in 5 (4.4%). Finally, ten (8.3%) patients were referred to other specialists. Conclusions: During the ambulatory follow-up of patients with SLE in an ADU, the frequency of consultations for symptoms and illnesses no related to SLE may be higher than those secondary to SLE, highlighting the need of a global and multidisciplinary management of these patients.

Bibliographic References

  • Barber C, Gold WL, Fortin PR. Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol. 2011; 23:358-65.
  • Bruce IN. Not only but also: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology 2005;44:1492-502.
  • Hochberg, MC. Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 1997; 40:1725.
  • Jimenez-Alonso J, Hidalgo-Tenorio C, Sabio-Sánchez JM, Jáimez-Gámiz L. Lupus Eritematoso sistémico. En Manual de enfermedades sistémicas. Ed. Ergon. 2007; 3-49.
  • Manzi S, Selzer F, Sutton-Tyrrel K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42:51-60.
  • Navarrete-Navarrete N, Peralta-Ramírez MI, Sabio-Sánchez JM, et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom. 2010;79:107-15.
  • Peralta-Ramirez MI, Jiménez-Alonso J, Godoy-García JF, Pérez-García M. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus Psychosom Med. 2004;66:788-94.
  • Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, et al. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical aterosclerosis in patients with systemic lupus erythematosus. J Rheumatol. 2009;36:2204-11.
  • Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum. 2013 Feb 16. S0049-0172(12)00284-3. 10.1016/j.semarthrit.2012.12.002
  • Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008;35:2152-8.
Data source: Dialnet